Literature DB >> 28714381

Gemcitabine associated pseudocellulitis: A missed diagnosis.

Dalvir Gill1, Josh Schrader2, Matthew Kelly1, Fidel Martinez1, Wajihuddin Syed1, Jonathan Wright1.   

Abstract

We report a case of a 51-year-old male with past medical history significant for cholangiocarcinoma presented with two weeks of worsening bilateral lower extremity swelling and erythema. Patient has been on active chemotherapy for his cholangiocarcinoma with Gemcitabine weekly infusions. Physical exam was significant for bilaterally petechial rash coalescing into ecchymoses over the dorsum of the feet, sparing soles and toes, which dissipated into thinning petechiae more proximally. On labs he did not have any leukocytosis, his platelet count was 50 × 103/µL and basic metabolic panel was benign. Patient was started on Vancomycin for presumed cellulitis. Lower extremity ultrasound Doppler ruled out deep venous thrombosis. Patient did have biopsies bilaterally on his legs, which showed hypersensitivity reaction consistent with the diagnosis of pseudocellulitis. His Vancomycin was discontinued and his symptoms improved. Our case further supports that pseudocellulitis is underrecognized and underreported, potentially leading to unnecessary antibiotic exposure and unnecessary diagnostic work-up as seen unfortunately in our patient. Unnecessary antibiotic exposure is increasing the risk for clostridium difficile and or antibiotic resistance, therefore awareness of this reaction is critical, as to avoid unnecessary antibiotics, and costly diagnostic workups.

Entities:  

Keywords:  Pseudocellulitis; antibiotics; cellulitis

Mesh:

Substances:

Year:  2017        PMID: 28714381     DOI: 10.1177/1078155217719584

Source DB:  PubMed          Journal:  J Oncol Pharm Pract        ISSN: 1078-1552            Impact factor:   1.809


  3 in total

1.  Gemcitabine-induced pseudocellulitis: a case report and review of the literature.

Authors:  H Bami; C Goodman; G Boldt; M Vincent
Journal:  Curr Oncol       Date:  2019-10-01       Impact factor: 3.677

Review 2.  Bilateral Lower Limbs Cellulitis: A Narrative Review of an Overlooked Clinical Dilemma.

Authors:  Kuo-Lung Lai; Chien-Hao Tseng; Yu-Chuan Chuang; Po-Yu Liu
Journal:  Int J Gen Med       Date:  2022-06-09

3.  Qingyihuaji formula reverses gemcitabine resistant human pancreatic cancer through regulate lncRNA AB209630/miR-373/EphB2-NANOG signals.

Authors:  Peng Chen; Meiying Wang; Cuiping Wang
Journal:  Biosci Rep       Date:  2019-06-18       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.